Cargando…
The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia
BACKGROUND: Recent studies suggest that HMG-CoA reductase inhibitors ("statins") may have beneficial effects for patients at risk for some types of infections. We examined the effect of prior outpatient use of statins on mortality for patients hospitalized with community-acquired pneumonia...
Autores principales: | Mortensen, Eric M, Restrepo, Marcos I, Anzueto, Antonio, Pugh, Jacqueline |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1199623/ https://www.ncbi.nlm.nih.gov/pubmed/16042797 http://dx.doi.org/10.1186/1465-9921-6-82 |
Ejemplares similares
-
The impact of prior outpatient ACE inhibitor use on 30-day mortality for patients hospitalized with community-acquired pneumonia
por: Mortensen, Eric M, et al.
Publicado: (2005) -
Impact of prior outpatient antibiotic use on mortality for community acquired pneumonia: a retrospective cohort study
por: Mortensen, Eric M, et al.
Publicado: (2008) -
The impact of empiric antimicrobial therapy with a β-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia
por: Mortensen, Eric M, et al.
Publicado: (2006) -
Antimicrobial Treatment of Community-Acquired Pneumonia
por: Restrepo, Marcos I., et al.
Publicado: (2005) -
Impact of statins and ACE inhibitors on mortality after COPD exacerbations
por: Mortensen, Eric M, et al.
Publicado: (2009)